Rebecca B. Klisovic

机构：University Hospitals Seidman Cancer Center, Case Western Reserve University · ORCID：0000-0001-6028-7347

发表论文 171 篇 · 总被引 8330 次 · h-index 43

代表论文

• Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial (2021 · Leukemia · 被引 98)
• SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia (2022 · UNM’s Digital Repository (University of New Mexico) · 被引 85)
• Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia (2023 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 13)
• A phase 2a, single‐arm, open‐label study of tafasitamab, a humanized, Fc‐modified, anti‐CD19 antibody, in patients with relapsed/refractory B‐precursor cell acute lymphoblastic leukemia (2021 · Cancer · 被引 13)
• The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study (2021 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 13)
• 10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed FLT3 Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years (2024 · Blood · 被引 10)